相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Mesenchymal chondrosarcoma: An Australian multi-centre cohort study
Madeleine C. Strach et al.
CANCER MEDICINE (2023)
Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex
Jialin Mo et al.
ONCOGENE (2023)
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
Shigeto Nishikawa et al.
CANCERS (2023)
Chondrosarcoma: A Clinical Review
Aaron Gazendam et al.
JOURNAL OF CLINICAL MEDICINE (2023)
Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions
Antoine Gilbert et al.
CANCERS (2023)
Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings
Jun-Ho Kim et al.
CANCERS (2023)
HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice
Miwa Tanaka et al.
JCI INSIGHT (2023)
Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
Younes Dehneh et al.
Surgical Neurology International (2023)
Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas
Georgina E. Wood et al.
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting (2023)
Systemic Therapy for Chondrosarcoma
Adam Rock et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)
Primary intra- and extradural extramedullary mesenchymal chondrosarcoma with isolated punctate calcification: case report and literature review
Meigui Chen et al.
BMC NEUROLOGY (2022)
Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis
Wenqing Qi et al.
JOURNAL OF PATHOLOGY (2022)
Extraskeletal Mesenchymal Chondrosarcoma of the Uterus
Yurimi Lee et al.
DIAGNOSTICS (2022)
Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls
Bin Xu et al.
GENES CHROMOSOMES & CANCER (2022)
Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report
Veronika Blum et al.
FRONTIERS IN ONCOLOGY (2022)
Retroperitoneal mesenchymal chondrosarcoma with metastasis to iliac vein: A rare case report and review of the literature
Mahsa Masjedi Esfahani et al.
CLINICAL CASE REPORTS (2022)
CT and MRI findings of intracranial extraskeletal mesenchymal chondrosarcoma-a case report and literature review
Jixiang Chu et al.
TRANSLATIONAL CANCER RESEARCH (2022)
Primary mesenchymal chondrosarcoma of the adult lumbar spine: a case report and review of the literature
Maoqiang Lin et al.
TRANSLATIONAL CANCER RESEARCH (2022)
Rare malignant primary spinal intradural extramedullary mesenchymal chondrosarcoma: a case report and literature review
Yunda Wang et al.
TRANSLATIONAL CANCER RESEARCH (2022)
A Rare Case Report of Mesenchymal Chondrosarcoma with Pancreatic Metastasis
Jian-Jiun Chen et al.
MEDICINA-LITHUANIA (2022)
Effect of surgery and radiotherapy on overall survival in patients with chondrosarcoma: A SEER-based study
Miao Wang et al.
JOURNAL OF ORTHOPAEDIC SURGERY (2022)
Mesenchymal chondrosarcoma of the chest wall in an adolescent patient: A case report and brief review of the literature
Marti Goldenberg et al.
CANCER REPORTS (2022)
NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study
Wei Chen et al.
HISTOPATHOLOGY (2021)
Mesenchymal chondrosarcoma: imaging features and clinical findings
Soleen Ghafoor et al.
SKELETAL RADIOLOGY (2021)
MEK inhibitors for the treatment of non-small cell lung cancer
Jing Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Proton Radiation Therapy for Pediatric Skull Base Chondrosarcomas
M. Ioakeim-Ioannidou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study
Madiha Syed et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2021)
Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
Pawel Lukasik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Rare case report and literature review of intracranial mesenchymal chondrosarcoma
Li-Yang Fu et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
Chao Dong et al.
FRONTIERS IN PHARMACOLOGY (2021)
Chondrosarcoma-from Molecular Pathology to Novel Therapies
Agnieszka E. Zajac et al.
CANCERS (2021)
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma
Warren Chow et al.
CANCER (2020)
Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis
Kamil M. Amer et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2020)
NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma
Ken-ichi Yoshida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Primary intraocular mesenchymal chondrosarcoma: a histopathological surprise in an enucleated eye
Ratnesh Ranjan et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2020)
OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases
Kun Yao et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma
Ghazal Tansir et al.
CLINICAL SARCOMA RESEARCH (2020)
Therapeutic development and current uses of BCL-2 inhibition
Andrew W. Roberts
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Mesenchymal Chondrosarcoma of the Brain with Metastasis: A Case Report with Literature Review
Sandeep Bhardwaj et al.
JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE (2020)
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
Liguo Zhang et al.
CANCER CELL (2019)
Targeting AKT for cancer therapy
Maryam Shariati et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)
Javier Martin-Broto et al.
ONCOLOGIST (2019)
Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion
Shunichi Toki et al.
HUMAN PATHOLOGY (2018)
Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology
Marc El Beaino et al.
CURRENT ONCOLOGY REPORTS (2018)
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. G. Casali et al.
ANNALS OF ONCOLOGY (2018)
Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells
Eun-Hui Jeong et al.
CELLULAR ONCOLOGY (2018)
Extraskeletal Mesenchymal Chondrosarcoma
Komal Arora et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)
Andres Redondo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Primary Spinal Intradural Mesenchymal Chondrosarcoma with Several Local Regrowths Treated with Osteoplastic Laminotomies: A Case Report
Marek Derenda et al.
SURGERY JOURNAL (2017)
Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma
Hideo Morioka et al.
BMC CANCER (2016)
Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy
Nobuhito Araki et al.
EUROPEAN JOURNAL OF CANCER (2016)
Clinical Outcomes for Patients After Surgery and Radiation Therapy for Mesenchymal Chondrosarcomas
Karen De Amorim Bernstein et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line
Yvonne de Jong et al.
LABORATORY INVESTIGATION (2016)
Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma
Yin P. Hung et al.
MODERN PATHOLOGY (2016)
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
L. Paoluzzi et al.
CLINICAL SARCOMA RESEARCH (2016)
Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study
Anna Maria Frezza et al.
EUROPEAN JOURNAL OF CANCER (2015)
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
Akira Kawai et al.
LANCET ONCOLOGY (2015)
Central neurocytoma with ependymoma-like glial component
Fumi Kawakami et al.
BRAIN TUMOR PATHOLOGY (2015)
NY-ESO-1 (CTAG1B) expression in mesenchymal tumors
Makoto Endo et al.
MODERN PATHOLOGY (2015)
Mesenchymal Chondrosarcoma of Bone and Soft Tissue: A Systematic Review of 107 Patients in the Past 20 Years
Jie Xu et al.
PLOS ONE (2015)
Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms
Anne-Laure Trepant et al.
TUMOR BIOLOGY (2015)
Radiation Therapy Is Associated With Fewer Recurrences in Mesenchymal Chondrosarcoma
Satoshi Kawaguchi et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2014)
Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
Ioannis Panagopoulos et al.
ONCOLOGY REPORTS (2014)
Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene
Kunihiko Moriya et al.
PEDIATRICS INTERNATIONAL (2014)
Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets
Jolieke G. van Oosterwijk et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study
A. Italiano et al.
ANNALS OF ONCOLOGY (2013)
Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: The implication of a common progenitor cell?
Nozomi Matsumura et al.
NEUROPATHOLOGY (2013)
The Insulin Receptor: Both a Prototypical and Atypical Receptor Tyrosine Kinase
Stevan R. Hubbard
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Mesenchymal Chondrosarcoma Clinicopathologic Study of 20 Cases
Rachel J. Shakked et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas
Axel Le Cesne et al.
EUROPEAN JOURNAL OF CANCER (2012)
Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data
Lu Wang et al.
GENES CHROMOSOMES & CANCER (2012)
Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma
Danielle Meijer et al.
GENES CHROMOSOMES & CANCER (2012)
Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma
Kaja B. Nyquist et al.
PLOS ONE (2012)
Molecular Diagnosis in Ewing Family Tumors The Rizzoli Experience-222 Consecutive Cases in Four Years
Gabriella Gamberi et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Feasibility of Proton Beam Therapy for Chordoma and Chondrosarcoma of the Skull Base
Hiroshi Fuji et al.
SKULL BASE-AN INTERDISCIPLINARY APPROACH (2011)
FLI-1 Distinguishes Ewing Sarcoma From Small Cell Osteosarcoma and Mesenchymal Chondrosarcoma
Anna F. Lee et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases
Julie C. Fanburg-Smith et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2010)
FGF-receptor signalling controls neural cell diversity in the zebrafish hindbrain by regulating olig2 and sox9
Virginie Esain et al.
DEVELOPMENT (2010)
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
Judith V. M. G. Bovee et al.
NATURE REVIEWS CANCER (2010)
Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma
Sebastien Salas et al.
VIRCHOWS ARCHIV (2009)
Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults - Experiences of the CWS and COSS study groups
Tobias M. Dantonello et al.
CANCER (2008)
The clinical approach towards chondrosarcoma
Hans Gelderblom et al.
ONCOLOGIST (2008)
Management of primary spinal chondrosarcoma -: Report of two cases causing cord compression
DMS Prevedello et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2004)
The Cdx1 homeodomain protein: an integrator of posterior signaling in the mouse
D Lohnes
BIOESSAYS (2003)
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms
AA Sandberg et al.
CANCER GENETICS AND CYTOGENETICS (2003)
HES and HERP families: Multiple effectors of the Notch signaling pathway
T Iso et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma
S Naumann et al.
MODERN PATHOLOGY (2002)
Expression of transcription factors during oligodendroglial development
M Wegner
MICROSCOPY RESEARCH AND TECHNIQUE (2001)